A free on-demand Webinar brought to you by |
Sponsored by:
Menaquinone-7 (MK): The Essential Vitamin K for Bone and Heart Health
Date: On Demand
Time: 2pm EDT
Length: 60 minutes
Click
HERE
to register.
Description:
For many years it was thought that vitamin K function was exclusively
related to blood coagulation. However, over the past decade vitamin K also
has been linked to bone and cardiovascular health.
Natural vitamin K2 has been shown in laboratory experiments to be
effective in preventing bone loss, promoting bone integrity, significantly
reducing the incidence of arterial calcification and promoting
cardiovascular health.
Discover the benefits of natural vitamin K2 in this vibrant, engaging
Webinar presented by Dr. Schurgers. Don’t miss this opportunity to learn
about:
- The different sources of vitamin K and their efficacy
- The latest clinical research supporting natural vitamin K2’s role in
bone and heart health
- Why vitamin K2 as menaquinone 7 (MK-7) is the best source of
supplemental vitamin K
Presenter:
 Leon Johannes Schurgers, Ph.D., is a renowned
research scientist specializing in the role of vitamin K in the field of
bone health and cardiovascular health. He is one of the chief researchers
for the division on vitamin K research at the Cardiovascular Research
Institute (CARIM), the largest research institute of the University of
Maastricht in The Netherlands.
Schurgers defended his doctorate thesis at CARIM on the role of vitamins
K1 and K2 in bone metabolism and cardiovascular disease. He received a
post-doc position at VitaK in 2001 and was appointed vice president and
scientific director in 2004. In 2007, he also became an honorary senior
scientist at CARIM. He is a member of the American Heart Association, the
American Society of Bone and Mineral Research, and the International Society
of Thrombosis and Haemostasis. Schurgers also is a board member of KEQAS,
the worldwide vitamin K external quality assurance scheme. www.KEQAS.com
For the past six years, he has served as vice president at VitaK Inc., a
wholly-owned company of the University of Maastricht Holding Co., where he
leads the effort to consult global markets about commercial opportunities
stemming from vitamin K Research at CARIM. www.vitak.com To date, VitaK and
CARIM have assisted in the development of health care products related to
cardiovascular health, rheumatic arthritis, osteoporosis prevention and
vascular diagnostics. Schurgers combines his executive role at VitaK with
his appointment as senior scientist at the Cardiovascular Research Institute
Maastricht. |
